How Microfluidic approaches in lung cancer detection?5 answersMicrofluidic approaches play a crucial role in lung cancer detection by offering high-throughput and sensitive methods for analyzing circulating tumor DNA (ctDNA). Surface-enhanced Raman spectroscopy (SERS) integrated with signal amplification strategies in a microfluidic chip enables the detection of prognostic ctDNAs with high sensitivity. Additionally, a microfluidic chip system utilizing specific tumor biomarkers like hexaminolevulinate (HAL) has shown promise in concentrating and identifying tumor cells in pleural effusion, aiding in clinical detection. Furthermore, a novel microsensor technology, Electric-Field-Induced Released and Measurement (EFIRM) Liquid Biopsy, offers a non-PCR and non-NGS-based multiplex platform for detecting lung cancer-associated ultra-short ctDNA with high accuracy. These advancements highlight the potential of microfluidic approaches in enhancing the efficacy of lung cancer diagnosis and prognosis.
What are the advantages of microfluidics?4 answersMicrofluidics offers several advantages in various fields of biotechnology. These include reduced chemical and sample consumption, increased energy and mass transfer, and smaller device size. In the context of assisted reproduction, microfluidics enables the selection of high-quality motile sperm cells with non-damaged DNA, leading to greater success in insemination and enhanced pregnancy rates. In biochemical operations, microfluidic devices provide smaller tool size, lower reagent use, faster response kinetics, increased parallelism, and automation, resulting in lower test costs and faster operation. Microfluidic devices also offer high heat and mass transfer, good process control, and reduced energy consumption and waste generation in separation and purification techniques. Additionally, microfluidics allows for precise control of hydrodynamic and physicochemical microenvironments, facilitating the study of biofilms and advancements in infection models and characterization methods.
What are the amounts of antibody and wash used in microfluidic lab on chip devices for assays?5 answersMicrofluidic lab-on-chip devices for assays use varying amounts of antibody and wash solutions. In one study, a high-throughput microfluidic platform was capable of quantitating up to 384 biomarkers using pairs of capture and detection antibodies, but the specific amounts of antibody and wash used were not mentioned. Another study mentioned the advantages of microfluidic technology, including the use of only a fraction of the staining reagents generally needed for flow cytometry and only 30,000 cells per sample, but did not provide specific amounts of antibody and wash. A cost-effective lab-on-a-disc design for simultaneous detection of multiple protein biomarkers mentioned a significant reduction in the amount of washing buffer used, but did not specify the exact amounts of antibody and wash. A pneumatically gated microfluidic communicating vessel chip was developed for immunomagnetic ELISA, but the amounts of antibody and wash used were not mentioned. Therefore, the specific amounts of antibody and wash used in microfluidic lab-on-chip devices for assays are not provided in the abstracts.
How much antibody is needed for elisa for a microfluidic lab on chip device?5 answersThe amount of antibody needed for ELISA in a microfluidic lab-on-a-chip device varies depending on the specific design and assay requirements. In one study, the ELISA-on-a-chip utilized 70 µL of detection antibody. Another study reported a limit of detection of 20 pM for rabbit IgG antibody detection using an autonomous ELISA on a microfluidic paper-based analytical device (µPAD). In a thermoelectric ELISA method, the concentration of the analyte was determined by detecting the heat of the enzymatic reaction between glucose oxidase conjugated to an IgG detection antibody and glucose. Additionally, a miniature 96 sample ELISA-lab-on-a-chip used a simple microfluidics system and detected Staphylococcal Enterotoxin B (SEB) at concentrations as low as 0.1 ng ml(-1). Therefore, the amount of antibody needed for ELISA in a microfluidic lab-on-a-chip device can vary depending on the specific assay and detection requirements, and the design of the device.
How can biomimetic integration techniques be used to improve the performance of microfluidic systems?5 answersBiomimetic integration techniques can be used to improve the performance of microfluidic systems. By using bio-inspired structural and functional designs, biomimetic microfluidic systems can overcome the limitations of current devices, such as anti-fouling, smart, and dynamic response inside the microchannels under different environments. These systems can incorporate biomimetic features like self-diagnosis and self-repair capabilities, extending their useful lifetime. Through multidisciplinary approaches, bio-inspired microfluidics can create biomimetic microenvironments that mimic the physiological features of organs, enabling the construction of high-fidelity human organ structures in vitro. By integrating biomimetic functions, such as chemotaxis and precision control of flow behavior, microfluidic systems can achieve performance characteristics beyond current devices. These advancements in biomimetic microfluidics offer new ideas for the design and application of smart microfluidics, contributing to the development of soft matter, multi-functional, and smart biomimetic devices.
How can microfluidic sensors be used to determine the concentration of metabolites?3 answersMicrofluidic sensors can be used to determine the concentration of metabolites through various methods. One approach is using electrophoresis, where an electric field is applied across a microfluidic channel to drive charged particles towards or away from electrodes. Another method involves using optical sensors with fiber tips integrated into the microfluidic chip, allowing real-time monitoring of concentration and temperature. Additionally, a microfluidic sensor based on an array of hydrogel-entrapped enzymes can simultaneously detect different concentrations of the same analyte or multiple analytes in real time. These sensors are easy to fabricate and eliminate the possibility of cross talk between enzymes. Furthermore, bioanalytical microfluidic sensors offer the advantages of microsystems, allowing for on-line measurement, bioassays, and quasi-continuous assays like immunoassays. Overall, microfluidic sensors provide a versatile and efficient platform for determining the concentration of metabolites.